Skip to content
Clinical Trials – home
Therapeutic area

Pregnancy, puerperium and perinatal conditions – page 8

  • 93 clinical trials
  • 52 recruiting
  • 63 conditions
  • 25 countries

Conditions in this area

63 conditions with trials, the busiest first

Clinical trials in Pregnancy, puerperium and perinatal conditions

93 trials across Europe, recruiting first

Type of trial
Recruitment status
Quick filters

93 clinical trials

Cerebral palsy+5

Not recruiting

Study on Valbenazine for Treating Dyskinesia in Children and Adults with Cerebral Palsy

Investigational
Countries:BelgiumBelgium
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Valbenazine Ditosylate
  • Sponsor:Neurocrine Biosciences Inc.

Study on Methotrexate, Tafasitamab, Lenalidomide, and Rituximab for Patients with Primary Central Nervous System Lymphoma Not Eligible for Stem Cell Transplant

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Lenalidomide
  • Sponsor:University Of Cologne

Long-Term Study on Aflibercept for Retinopathy of Prematurity in Infants

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:0–17 years
  • Substances:Aflibercept
  • Sponsor:Bayer AG

Study Comparing Balloon with Oxytocin and Oral Misoprostol for Inducing Labor in First-Time Mothers with Premature Rupture of Membranes at Term

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years
  • Substances:Amoxicillin
  • Sponsor:CHU Gabriel-Montpied

Perineal injury

Not recruiting

Study on Amoxicillin and Clavulanic Acid to Prevent Infection in Women with Obstetric Perineal Tear

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years
  • Substances:Amoxicillin
  • Sponsor:Region Hovedstaden

Short stature+3

Not recruiting

Study on the Safety and Effectiveness of Somapacitan for Children with Short Stature Due to Noonan Syndrome, Turner Syndrome, Small for Gestational Age, or Idiopathic Short Stature

InvestigationalNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:0–17 years
  • Substances:Somapacitan
  • Sponsor:Novo Nordisk A/S

Netherton's syndrome

Not recruiting

Study to Evaluate the Effectiveness of Spesolimab in Treating Patients with Netherton Syndrome

Investigational
Countries:AustriaAustria
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Spesolimab
  • Sponsor:Boehringer Ingelheim Espana S.A.

Netherton's syndrome

Not recruiting

Study on the Safety of DS-2325a for Patients with Netherton Syndrome

Registered drug
Countries:FranceFrance
  • Participants:18–64 years
  • Substances:Ds-2325A
  • Sponsor:Daiichi Sankyo Inc.

Study on Mecasermin Rinfabate for Preventing Chronic Lung Disease in Extremely Premature Babies

InvestigationalNo placebo
Countries:FinlandFinland
  • Participants:0–17 years
  • Substances:Mecasermin Rinfabate
  • Sponsor:Ohb Neonatology Limited

Substances studied in this area

The therapies tested most often in Pregnancy, puerperium and perinatal conditions trials.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.